111 related articles for article (PubMed ID: 7491754)
1. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity.
Gripon P; Le Seyec J; Rumin S; Guguen-Guillouzo C
Virology; 1995 Nov; 213(2):292-9. PubMed ID: 7491754
[TBL] [Abstract][Full Text] [Related]
2. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus.
Glebe D; Aliakbari M; Krass P; Knoop EV; Valerius KP; Gerlich WH
J Virol; 2003 Sep; 77(17):9511-21. PubMed ID: 12915565
[TBL] [Abstract][Full Text] [Related]
3. A short N-proximal region in the large envelope protein harbors a determinant that contributes to the species specificity of human hepatitis B virus.
Chouteau P; Le Seyec J; Cannie I; Nassal M; Guguen-Guillouzo C; Gripon P
J Virol; 2001 Dec; 75(23):11565-72. PubMed ID: 11689638
[TBL] [Abstract][Full Text] [Related]
4. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity.
Bruss V; Hagelstein J; Gerhardt E; Galle PR
Virology; 1996 Apr; 218(2):396-9. PubMed ID: 8610467
[TBL] [Abstract][Full Text] [Related]
5. Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP.
Liu H; Zakrzewicz D; Nosol K; Irobalieva RN; Mukherjee S; Bang-Sørensen R; Goldmann N; Kunz S; Rossi L; Kossiakoff AA; Urban S; Glebe D; Geyer J; Locher KP
Nat Commun; 2024 Mar; 15(1):2476. PubMed ID: 38509088
[TBL] [Abstract][Full Text] [Related]
6. Structural basis of hepatitis B virus receptor binding.
Asami J; Park JH; Nomura Y; Kobayashi C; Mifune J; Ishimoto N; Uemura T; Liu K; Sato Y; Zhang Z; Muramatsu M; Wakita T; Drew D; Iwata S; Shimizu T; Watashi K; Park SY; Nomura N; Ohto U
Nat Struct Mol Biol; 2024 Mar; 31(3):447-454. PubMed ID: 38233573
[TBL] [Abstract][Full Text] [Related]
7. Targeting the YXXΦ Motifs of the SARS Coronaviruses 1 and 2 ORF3a Peptides by In Silico Analysis to Predict Novel Virus-Host Interactions.
Kakkanas A; Karamichali E; Koufogeorgou EI; Kotsakis SD; Georgopoulou U; Foka P
Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008946
[TBL] [Abstract][Full Text] [Related]
8. A single hepatitis B virus genome with a reporter allows the entire viral life cycle to be monitored in primary human hepatocytes.
Sumiyadorj A; Murai K; Shimakami T; Kuroki K; Nishikawa T; Kakuya M; Yamada A; Wang Y; Ishida A; Shirasaki T; Kawase S; Li YY; Okada H; Nio K; Kawaguchi K; Yamashita T; Sakai Y; Duger D; Mizukoshi E; Honda M; Kaneko S
Hepatol Commun; 2022 Sep; 6(9):2441-2454. PubMed ID: 35691027
[TBL] [Abstract][Full Text] [Related]
9. Structure of the bile acid transporter and HBV receptor NTCP.
Asami J; Kimura KT; Fujita-Fujiharu Y; Ishida H; Zhang Z; Nomura Y; Liu K; Uemura T; Sato Y; Ono M; Yamamoto M; Noda T; Shigematsu H; Drew D; Iwata S; Shimizu T; Nomura N; Ohto U
Nature; 2022 Jun; 606(7916):1021-1026. PubMed ID: 35580629
[TBL] [Abstract][Full Text] [Related]
10. Entry Inhibitors of Hepatitis B and D Viruses.
Yang Y; Xie Y
Adv Exp Med Biol; 2022; 1366():199-205. PubMed ID: 35412142
[TBL] [Abstract][Full Text] [Related]
11. Pathogenicity and virulence of Hepatitis B virus.
Chuang YC; Tsai KN; Ou JJ
Virulence; 2022 Dec; 13(1):258-296. PubMed ID: 35100095
[TBL] [Abstract][Full Text] [Related]
12. 5' preS1 Mutations To Prevent Large Envelope Protein Expression from Hepatitis B Virus Genotype A or Genotype D Markedly Increase Polymerase-Envelope Fusion Protein.
Zhang J; Yuan Q; Wang Y; Wang Y; Yuan W; Xia N; Wen Y; Li J; Tong S
J Virol; 2022 Mar; 96(5):e0172321. PubMed ID: 35019714
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Viral Membrane Fusion by Peptides and Approaches to Peptide Design.
Düzgüneş N; Fernandez-Fuentes N; Konopka K
Pathogens; 2021 Dec; 10(12):. PubMed ID: 34959554
[TBL] [Abstract][Full Text] [Related]
14. Envelope Proteins of Hepatitis B Virus: Molecular Biology and Involvement in Carcinogenesis.
Inoue J; Sato K; Ninomiya M; Masamune A
Viruses; 2021 Jun; 13(6):. PubMed ID: 34208172
[TBL] [Abstract][Full Text] [Related]
15. HBV Pre-S1-Derived Myristoylated Peptide (Myr47): Identification of the Inhibitory Activity on the Cellular Uptake of Lipid Nanoparticles.
Nanahara M; Chang YT; Somiya M; Kuroda S
Viruses; 2021 May; 13(5):. PubMed ID: 34067884
[TBL] [Abstract][Full Text] [Related]
16. A pocket-factor-triggered conformational switch in the hepatitis B virus capsid.
Lecoq L; Wang S; Dujardin M; Zimmermann P; Schuster L; Fogeron ML; Briday M; Schledorn M; Wiegand T; Cole L; Montserret R; Bressanelli S; Meier BH; Nassal M; Böckmann A
Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33879615
[TBL] [Abstract][Full Text] [Related]
17. A Not-So-Ancient Grease History: Click Chemistry and Protein Lipid Modifications.
Suazo KF; Park KY; Distefano MD
Chem Rev; 2021 Jun; 121(12):7178-7248. PubMed ID: 33821625
[TBL] [Abstract][Full Text] [Related]
18. Protein N-myristoylation: functions and mechanisms in control of innate immunity.
Wang B; Dai T; Sun W; Wei Y; Ren J; Zhang L; Zhang M; Zhou F
Cell Mol Immunol; 2021 Apr; 18(4):878-888. PubMed ID: 33731917
[TBL] [Abstract][Full Text] [Related]
19. Intracellular Trafficking of HBV Particles.
Jiang B; Hildt E
Cells; 2020 Sep; 9(9):. PubMed ID: 32887393
[TBL] [Abstract][Full Text] [Related]
20. The N-Terminus Makes the Difference: Impact of Genotype-Specific Disparities in the N-Terminal Part of The Hepatitis B Virus Large Surface Protein on Morphogenesis of Viral and Subviral Particles.
Jiang B; Wen X; Wu Q; Bender D; Carra G; Basic M; Kubesch A; Peiffer KH; Boller K; Hildt E
Cells; 2020 Aug; 9(8):. PubMed ID: 32823751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
